Acquisitions and Joint Ventures
Acquired a comprehensive list of ANDAs and generic products from Takeda Pharmaceuticals
Acquired a developer of a dermatological device used to treat actinic keratoses
Joint Venture with a focus on emerging markets
Acquired majority stake in a multinational generic manufacturer with established North America presence and a strong dermatology franchise
Acquired a manufacturer of controlled substances with an API facility
Acquired controlled substance manufacturing assets.
Acquired Alkaloida’s controlled substance APIs and dosage form manufacturing plant.
Acquired manufacturer of cephalosporin API holding USA and European approvals
Helped initiate entry in ophthalmology
Initial stake investment in 1996, 100% takeover in 1999. Acquired Cephalexin and 7ADCA actives manufacturing site
Initial stake investment in 1996, 100% takeover in 2002. Acquired plant with USFDA and UKMHRA approvals for oral dosage forms
Helped initiate entry in chest and respiratory therapy areas
Helped initiate entry in oncology and gynecology
Acquired an API plant in Ahmednagar, Maharashtra
* All logos and trademarks are the property of the relevant trademark owners
We wish to bring to the notice of all concerned that Fake-e-mails are being sent in the name of Sun Pharma for Job openings with the intention of committing fraud and illegally obtaining money from people. In case you receive any mail for Job Opening or Walk-In-Interview and are asked to deposit money/refundable security amount, purporting to be from Sun Pharma, you are advised not to respond. Sun Pharma never asks for money/refundable security amount to attend any interviews or Job Openings.
Please check www.sunpharma.com the official website of the company to get the contact details and enquire with the company to confirm if the Job Openings are genuine. Do not respond to any fraudulent communication and be wary of responding to the bogus text messages which request for data and promise employment.
We shall not accept any liability towards the representation made in any fraudulent communication or its consequences and such fraudulent communication shall not be treated as any kind of offer or representation by Sun Pharma.